Terunuma H - Search Results

1

Exploring the Utility of NK Cells in COVID-19.

Deng X, Terunuma H, Nieda M. Deng X, et al. Among authors: terunuma h. Biomedicines. 2022 Apr 26;10(5):1002. doi: 10.3390/biomedicines10051002. Biomedicines. 2022. PMID: 35625739 Free PMC article. Review.

2

Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging.

Deng X, Terunuma H, Nieda M. Deng X, et al. Among authors: terunuma h. Biomedicines. 2021 May 17;9(5):557. doi: 10.3390/biomedicines9050557. Biomedicines. 2021. PMID: 34067700 Free PMC article. Review.

3

NK cell-based autologous immune enhancement therapy (AIET) for cancer.

Terunuma H, Deng X, Nishino N, Watanabe K. Terunuma H, et al. J Stem Cells Regen Med. 2013 Apr 30;9(1):9-13. doi: 10.46582/jsrm.0901003. eCollection 2013. J Stem Cells Regen Med. 2013. PMID: 24693203 Free PMC article.

4

Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.

Terunuma H, Deng X, Dewan Z, Fujimoto S, Yamamoto N. Terunuma H, et al. Int Rev Immunol. 2008;27(3):93-110. doi: 10.1080/08830180801911743. Int Rev Immunol. 2008. PMID: 18437601 Review.

5

Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells.

Deng X, Terunuma H, Terunuma A, Takane T, Nieda M. Deng X, et al. Among authors: terunuma h, terunuma a. Int Immunopharmacol. 2014 Oct;22(2):486-91. doi: 10.1016/j.intimp.2014.07.036. Epub 2014 Aug 11. Int Immunopharmacol. 2014. PMID: 25131561

6

Dendritic cells cross-talk with tumour antigen-specific CD8⁺ T cells, Vγ9γδT cells and Vα24NKT cells in patients with glioblastoma multiforme and in healthy donors.

Eiraku Y, Terunuma H, Yagi M, Deng X, Nicol AJ, Nieda M. Eiraku Y, et al. Among authors: terunuma h. Clin Exp Immunol. 2018 Oct;194(1):54-66. doi: 10.1111/cei.13185. Epub 2018 Sep 14. Clin Exp Immunol. 2018. PMID: 30009488 Free PMC article.

7

Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells.

Deng X, Terunuma H, Nieda M, Xiao W, Nicol A. Deng X, et al. Among authors: terunuma h. Int Immunopharmacol. 2012 Dec;14(4):593-605. doi: 10.1016/j.intimp.2012.09.014. Epub 2012 Oct 9. Int Immunopharmacol. 2012. PMID: 23063974

8

Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.

Nieda M, Terunuma H, Eiraku Y, Deng X, Nicol AJ. Nieda M, et al. Among authors: terunuma h. Exp Dermatol. 2015 Jan;24(1):35-41. doi: 10.1111/exd.12581. Epub 2014 Dec 8. Exp Dermatol. 2015. PMID: 25363560

9

Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients.

Dewan MZ, Takada M, Terunuma H, Deng X, Ahmed S, Yamamoto N, Toi M. Dewan MZ, et al. Among authors: terunuma h. Biomed Pharmacother. 2009 Nov;63(9):703-6. doi: 10.1016/j.biopha.2009.02.003. Epub 2009 Feb 25. Biomed Pharmacother. 2009. PMID: 19269774

10

Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.

Dewan MZ, Terunuma H, Toi M, Tanaka Y, Katano H, Deng X, Abe H, Nakasone T, Mori N, Sata T, Yamamoto N. Dewan MZ, et al. Among authors: terunuma h. Cancer Sci. 2006 Dec;97(12):1381-7. doi: 10.1111/j.1349-7006.2006.00319.x. Epub 2006 Sep 21. Cancer Sci. 2006. PMID: 16995875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters